£585
−91%vs Apr 2025Active03808130Private limited companyBristol
SOLUPHARM LIMITED
Significant control: Susan Bolton (25–50%), Christopher James Charles Bolton (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Solupharm Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SOLUPHARM LIMITED is an active private limited company (company number 03808130) incorporated on 15 July 1999, registered in Bristol. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2026, showing net assets of £585 and cash of £1,225, with 2 employees on average. Net assets fell 91% on the prior period (£6,233). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the lower half of 50 comparable companies in Bristol (median £17k, upper quartile £164k).
02
Ownership and control
- Susan Bolton
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Christopher James Charles Bolton
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 July 199927 yrs ago
- Next accounts due
- 30 January 2028in 464 days
- Confirmation statement due
- 29 July 2027in 279 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£1,225
−84%vs Apr 2025Not reported
2
No changevs Apr 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2026 | £585 | £1,225 | £152 | — | — | — | 2 |
| 30 April 2025 | £6,233 | £7,553 | — | — | — | — | 2 |
| 30 April 2024 | £14k | £18k | — | — | — | — | 2 |
Cash per employee£612Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £585 at 30 April 2026
- Net assets down 25% or more on the prior period-90.6% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 15 July 1999
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 464 days
- Confirmation statement duein 279 days
- Accounts period endNet assets £585 · small accounts
- Accounts period endNet assets £6,233 · small accounts
- Accounts period endNet assets £14k · small accounts
- Incorporated
08
Similar companies in Bristol
- WEATHER RESEARCH LIMITEDRadstock · inc. Apr 2003
- ALFORD IP LIMITEDTrowbridge · inc. Dec 2003
- DNA WORLDWIDE GROUP LTDFrome · inc. Mar 2004
- CURIA HOLDINGS (UK) LIMITEDBristol · inc. May 2004
- BINX HEALTH LIMITEDTrowbridge · inc. Jul 2005
- DNA LEGAL LIMITEDFrome · inc. Oct 2006
All companies incorporated on 15 July 1999 · in Jul 1999.
09
Reminders for SOLUPHARM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.